EMBL Australia Group Leader Associate Professor Cryle co-led a team of researchers who have identified a key part of the process by which a common clinical antibiotic is formed – a finding that could potentially pave the way for novel compounds to tackle the problem of bacterial resistance. With ‘superbugs’ responsible for around 700,000 deaths globally a year, new types of antibiotics are urgently needed.
Keep up to date with all the latest EMBL Australia news and events.